https://orcid.org/0000-0002-5386-5396
References
- Sfiniadaki E, Tsiara I, Theodossiadis P, et al. Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmol Ther. 2019;8:227–234.
- Tarabishy AB, Schulte M, Papaliodis GN, et al. Wegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;55:429–444.
- Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–498.
- Ismailova DS, Abramova JV, Novikov PI, et al. Clinical features of different orbital manifestations of granulomatosis with polyangiitis. Graefes Arch Clin Exp Ophthalmol. 2018;256:1751–1756.
- Fries JF, Hunder GG, Bloch DA, et al. The American college of rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33:1135–1136.
- Tan LT, Davagnanam I, Isa H, et al. Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement. Ophthalmology. 2014;121:1304–1309.
- Isa H, Lightman S, Luthert PJ, et al. Histopathological features predictive of a clinical diagnosis of ophthalmic granulomatosis with polyangiitis (GPA). Int J Clin Exp Pathol. 2012;5684–689.
- Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings. Arch Pathol Lab Med. 2014;138:1110–1114.
- Pakrou N, Selva D, Leibovitch I. Wegener’s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35:284–292.
- Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–232.